The role of nitric oxide

Rheumatology

Volumn 45, Issue SUPPL. 3, 2006, Pages

  Kolb Bachofen, Victoria ^a   Kuhn, A ^a   Suschek, C V ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; DRUG MECHANISM; DRUG SELECTIVITY; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATORY DISEASE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

ENDOTHELIN-1; HUMANS; INFLAMMATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECEPTORS, ENDOTHELIN;

EID: 33749016195     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel287     Document Type: Review

References (10)

1. de Nucci G, Thomas R, D'Orleans-Juste P et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988;85:9797-800.
2. Malmstrom RE, Weitzberg E. Endothelin and nitric oxide in inflammation: could there be a need for endothelin-blocking anti-inflammatory drugs? J Hypertens 2004;22:27-9.
3. Hocher B, Schwarz A, Slowinski T et al. In-vivo interaction of nitric oxide and endothelin. J Hypertens 2004;22:111-9.
4. Hocher B, Schwarz A, Fagan KA et al. Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice. Am J Respir Cell Mol Biol 2000;23:19-26.
5. Kolb H, Kolb-Bachofen V. Nitric oxide in autoimmune disease: Cytotoxic or regulatory mediator? Immunol Today 1998;19:556-61.
6. Bruch-Gerharz D, Schnorr O, Suschek C et al. Arginase 1 overexpression in psoriasis: Limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation. Am J Pathol 2003;162:203-11.
7. Soeters PB, Hallemeesch MM, Bruins MJ, van Eijk HM, Deutz NE. Quantitative in vivo assessment of arginine utilization and nitric oxide production in endotoxemia. Am J Surg 2002;183:480-8.
8. Suschek CV, Schnorr O, Kolb-Bachofen V. The role of iNOS in chronic inflammatory processes in vivo: Is it damage-promoting, protective, or active at all? Curr Mol Med 2004;4:763-75.
9. Biecker E, Neef M, Sagesser H, Shaw S, Koshy A, Reichen J. Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis. Liver Int 2004;24:345-53.
10. Gonon AT, Erbas D, Broijersen A, Valen G, Pernow J. Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2004;286:H1767-74.